JAMA Netw Open 6:e2336400 Kelly AS, Auerbach P, Barrientos-Perez M et al (2020) A randomized, controlled trial of liraglutide for adolescents with obesity
Serious Complications (Very Rare): Extremely rare but possible severe side effects can include congestive heart failure in individuals with certain heart conditions, or polycythemia vera (a blood disorder)
However, raw incidence numbers do not reflect individual risk
Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial
By purchasing Lipo-C in a package, you can destroy fat cells without destroying the piggy bank (Pkg/4 $120)
Clinical Guidelines and Practice Implications Current healthcare policies often create obstacles for patients who need timely anti-obesity medication (AOM) intervention